资讯库
更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
龙沙旗下Synaffix与Qurient合作开发双载荷ADC药物 - 医药通讯
Lonza’s Synaffix and Qurient team up on dual-payload ADC The Pharma Letter
RION与龙沙合作扩大基于外泌体的治疗药物生产规模 - 新闻医学网
RION engages Lonza to scale manufacturing exosome based therapeutics News-Medical
Lonza旗下Synaffix与Qurient Therapeutics合作推进双载荷ADC药物开发 - 雅虎财经
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC Yahoo Finance
RION携手龙沙扩大基于外泌体的治疗药物生产规模 - 商业电讯
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics Business Wire
龙沙同意扩大RION基于外泌体疗法的生产规模——GEN《基因工程与生物技术新闻》报道
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics GEN - Genetic Engineering and Biotechnology News
现在为何说龙沙集团(LZAGY)是绝佳的“抄底”股票——纳斯达克解析
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now Nasdaq
以下原因说明朗盛集团(LZAGY)当前是绝佳的“抄底”良机——雅虎财经
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance